This observational study assessed the safety and adverse drug reactions (ADRs) of subcutaneous mistletoe (Viscum album) extract in cancer patients. A total of 1,923 patients receiving mistletoe as part of anthroposophic medicine were observed, with 14.7% reporting expected effects such as local reactions and mild fever. Only 8.4% of patients
